Literature DB >> 26268658

Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis.

Bruno B Andrade1, Nathella Pavan Kumar2, Eduardo P Amaral3, Nicolas Riteau3, Katrin D Mayer-Barber3, Kevin W Tosh3, Nolan Maier4, Elisabete L Conceição5, Andre Kubler6, Rathinam Sridhar7, Vaithilingam V Banurekha8, Mohideen S Jawahar8, Theolis Barbosa5, Vincent C Manganiello9, Joel Moss9, Joseph R Fontana9, Beatriz E Marciano10, Elizabeth P Sampaio10, Kenneth N Olivier10, Steven M Holland10, Sharon H Jackson11, Mahtab Moayeri4, Stephen Leppla4, Irini Sereti12, Daniel L Barber13, Thomas B Nutman14, Subash Babu15, Alan Sher3.   

Abstract

Pulmonary tuberculosis (TB) is characterized by oxidative stress and lung tissue destruction by matrix metalloproteinases (MMPs). The interplay between these distinct pathological processes and the implications for TB diagnosis and disease staging are poorly understood. Heme oxygenase-1 (HO-1) levels were previously shown to distinguish active from latent TB, as well as successfully treated Mycobacterium tuberculosis infection. MMP-1 expression is also associated with active TB. In this study, we measured plasma levels of these two important biomarkers in distinct TB cohorts from India and Brazil. Patients with active TB expressed either very high levels of HO-1 and low levels of MMP-1 or the converse. Moreover, TB patients with either high HO-1 or MMP-1 levels displayed distinct clinical presentations, as well as plasma inflammatory marker profiles. In contrast, in an exploratory North American study, inversely correlated expression of HO-1 and MMP-1 was not observed in patients with other nontuberculous lung diseases. To assess possible regulatory interactions in the biosynthesis of these two enzymes at the cellular level, we studied the expression of HO-1 and MMP-1 in M. tuberculosis-infected human and murine macrophages. We found that infection of macrophages with live virulent M. tuberculosis is required for robust induction of high levels of HO-1 but not MMP-1. In addition, we observed that CO, a product of M. tuberculosis-induced HO-1 activity, inhibits MMP-1 expression by suppressing c-Jun/AP-1 activation. These findings reveal a mechanistic link between oxidative stress and tissue remodeling that may find applicability in the clinical staging of TB patients.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26268658      PMCID: PMC4561190          DOI: 10.4049/jimmunol.1500942

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins.

Authors:  Andrei P Pomerantsev; Olga M Pomerantseva; Mahtab Moayeri; Rasem Fattah; Cynthia Tallant; Stephen H Leppla
Journal:  Protein Expr Purif       Date:  2011-08-07       Impact factor: 1.650

Review 2.  Matrix metalloproteinases in tuberculosis.

Authors:  P T Elkington; C A Ugarte-Gil; J S Friedland
Journal:  Eur Respir J       Date:  2011-06-09       Impact factor: 16.671

Review 3.  Tuberculosis.

Authors:  Alimuddin Zumla; Mario Raviglione; Richard Hafner; C Fordham von Reyn
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

4.  Heme oxygenase 1 polymorphisms and plasma concentrations in critically ill patients.

Authors:  Katri Saukkonen; Päivi Lakkisto; Mari A Kaunisto; Marjut Varpula; Liisa-Maria Voipio-Pulkki; Tero Varpula; Ville Pettilä; Kari Pulkki
Journal:  Shock       Date:  2010-12       Impact factor: 3.454

5.  Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1.

Authors:  Paul T G Elkington; Robert K Nuttall; Joseph J Boyle; Cecilia M O'Kane; Donna E Horncastle; Dylan R Edwards; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2005-09-01       Impact factor: 21.405

6.  Characterization of the interaction between anthrax toxin and its cellular receptors.

Authors:  Shihui Liu; Howard J Leung; Stephen H Leppla
Journal:  Cell Microbiol       Date:  2007-04       Impact factor: 3.715

Review 7.  Tuberculosis biomarkers discovery: developments, needs, and challenges.

Authors:  Robert S Wallis; Peter Kim; Stewart Cole; Debra Hanna; Bruno B Andrade; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

8.  Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients.

Authors:  Shigemitsu Ninomiya; Takashi Niimi; Shigeki Shimizu; Shigeki Sato; Hiroyuki Achiwa; Hidemi Ito; Kenji Akita; Hiroyoshi Maeda; Ryuzo Ueda
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2004-03       Impact factor: 0.670

9.  Influence of matrix metalloproteinase-1 gene -1607 (1G/2G) (rs1799750) promoter polymorphism on circulating levels of MMP-1 in chronic pancreatitis.

Authors:  K Sri Manjari; Pratibha Nallari; N Balakrishna; A Vidyasagar; B Prabhakar; A Jyothy; A Venkateshwari
Journal:  Biochem Genet       Date:  2013-05-05       Impact factor: 1.890

10.  MMP-1 drives immunopathology in human tuberculosis and transgenic mice.

Authors:  Paul Elkington; Takayuki Shiomi; Ronan Breen; Robert K Nuttall; Cesar Augusto Ugarte-Gil; Naomi F Walker; Luísa Saraiva; Bernadette Pedersen; Francesco Mauri; Marc Lipman; Dylan R Edwards; Brian D Robertson; Jeanine D'Armiento; Jon S Friedland
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

View more
  32 in total

1.  Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.

Authors:  Caian L Vinhaes; Deivide Oliveira-de-Souza; Paulo S Silveira-Mattos; Betania Nogueira; Ruiru Shi; Wang Wei; Xing Yuan; Guolong Zhang; Ying Cai; Clifton E Barry; Laura E Via; Kiyoshi F Fukutani; Bruno B Andrade; Katrin D Mayer-Barber
Journal:  Cytokine       Date:  2019-06-18       Impact factor: 3.861

2.  Emerging Role for Ferroptosis in Infectious Diseases.

Authors:  Eduardo Pinheiro Amaral; Sivaranjani Namasivayam
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo.

Authors:  Alissa C Rothchild; Gregory S Olson; Johannes Nemeth; Lynn M Amon; Dat Mai; Elizabeth S Gold; Alan H Diercks; Alan Aderem
Journal:  Sci Immunol       Date:  2019-07-26

Review 4.  The emerging role of gasotransmitters in the pathogenesis of tuberculosis.

Authors:  Krishna C Chinta; Vikram Saini; Joel N Glasgow; James H Mazorodze; Md Aejazur Rahman; Darshan Reddy; Jack R Lancaster; Adrie J C Steyn
Journal:  Nitric Oxide       Date:  2016-07-04       Impact factor: 4.427

5.  Attenuated heme oxygenase-1 responses predispose the elderly to pulmonary nontuberculous mycobacterial infections.

Authors:  Ranu Surolia; Suman Karki; Zheng Wang; Tejaswini Kulkarni; Fu Jun Li; Shikhar Vohra; Hitesh Batra; Jerry A Nick; Steven R Duncan; Victor J Thannickal; Adrie J C Steyn; Anupam Agarwal; Veena B Antony
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-30       Impact factor: 5.464

6.  Heme Oxygenase-1 Regulates Inflammation and Mycobacterial Survival in Human Macrophages during Mycobacterium tuberculosis Infection.

Authors:  Caitlyn R Scharn; Angela C Collins; Vidhya R Nair; Chelsea E Stamm; Denise K Marciano; Edward A Graviss; Michael U Shiloh
Journal:  J Immunol       Date:  2016-04-22       Impact factor: 5.422

Review 7.  Assessment of treatment response in tuberculosis.

Authors:  Neesha Rockwood; Elsa du Bruyn; Thomas Morris; Robert J Wilkinson
Journal:  Expert Rev Respir Med       Date:  2016-03-31       Impact factor: 3.772

Review 8.  The Interplay Between Systemic Inflammation, Oxidative Stress, and Tissue Remodeling in Tuberculosis.

Authors:  Eduardo P Amaral; Caian L Vinhaes; Deivide Oliveira-de-Souza; Betania Nogueira; Kevan M Akrami; Bruno B Andrade
Journal:  Antioxid Redox Signal       Date:  2020-06-19       Impact factor: 8.401

9.  Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international.

Authors:  Carolina Geadas; Sonia K Stoszek; David Sherman; Bruno B Andrade; Sudha Srinivasan; Carol D Hamilton; Jerrold Ellner
Journal:  Tuberculosis (Edinb)       Date:  2016-11-27       Impact factor: 2.973

Review 10.  Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?

Authors:  Hyun-Eui Park; Wonsik Lee; Min-Kyoung Shin; Sung Jae Shin
Journal:  Front Immunol       Date:  2021-06-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.